Nu Eyne validated their go-to-market approach and launched their US expansion soft landing with Hypergrowth support.
Nu Eyne is a leading medical R&D company specializing in electronic medicine, focusing on treatments for chronic diseases as well as innovations that prevent aging and promote longevity. With a mission to improve global health through advanced MedTech solutions, Nu Eyne sought to expand internationally and tap into the US healthcare ecosystem.
Led by CEO PK Kim, the company engaged Hypergrowth to validate its international expansion strategy, refine positioning, and connect with US-based advisors and investors to accelerate market entry.
-
Challenge: Lack of proven international strategy for entering highly competitive US MedTech market
-
Goal: Validate go-to-market plan, connect with US investors and advisors, and soft launch US expansion
-
Solution: Hypergrowth delivered tailored market entry support, content on expansion essentials, and direct mentoring with a MedTech expert to shape Nu Eyne’s international strategy